Epizyme reported $3.33M in Trade Debtors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Agios Pharmaceuticals AGIO:US $ 6.99M 1.14M
Amarin AMRN:US $ 149.36M 32.9M
Amgen AMGN:US $ 4765M 286M
Avrobio Inc AVRO:US 2.66M 330K
Biogen BIIB:US $ 2123M 12.8M
Bluebird Bio BLUE:US $ 12.66M 12.66M
Cerulean Pharma CERU:US $ 156.25K 2.8M
Daiichi Sankyo 4568:JP Y 276496M 18353M
Eisai 4523:JP Y 174606M 61730M
Epizyme EPZM:US $ 3.33M 3.79M
Exelixis EXEL:US $ 187.03M 5.53M
Gilead Sciences GILD:US $ 4566M 417M
GlaxoSmithKline GSK:LN 8.28B 777M
Glaxosmithkline GSK:US $ 8284M 777M
Karyopharm Therapeutics KPTI:US $ 18.75M 865K
Macrogenics MGNX:US $ 13.76M 31.49M
Mirati Therapeutics MRTX:US $ 1.96M 65.17M
Novartis NOVN:VX 8.63B 22M
Novartis NVS:US $ 8632M 22M
Regeneron Pharmaceuticals REGN:US $ 5452M 1546.6M
Seattle Genetics SGEN:US $ 387.17M 7.43M
Spectrum Pharmaceuticals SPPI:US $ 3.86M 0.33M
Vertex Pharmaceuticals VRTX:US $ 1100.37M 171.23M
Xencor XNCR:US $ 20.54M 5.22M